New combo therapy aims to shrink sarcomas
Disease control
Recruiting now
This early-stage trial tests whether giving a targeted drug (palbociclib) before immunotherapy (pembrolizumab) is safe and can help shrink tumors in people with certain soft tissue sarcomas. About 8 participants will receive the combination. The main goal is to check for side eff…
Phase: PHASE1 • Sponsor: John Rieth • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC